Harvard Bioscience (HBIO) Retained Earnings (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Retained Earnings of -$218.1 million for Q1 2026, down 4.7% year-over-year from -$228.9 million in Q1 2025, and down 1.59% quarter-over-quarter from -$214.7 million in Q4 2025.
Harvard Bioscience (HBIO) Retained Earnings (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Retained Earnings for 17 consecutive years, with -$218.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 4.7% year-over-year to -$218.1 million; the TTM figure through Mar 2026 stood at -$218.1 million (down 4.7% YoY), while the FY2025 annual figure was -$214.7 million, down 1270.2% from the prior year.
- Retained Earnings retreated to -$218.1 million in Q1 2026 per HBIO's latest filing, from -$214.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$10.7 million in Q1 2022 and bottomed at -$218.1 million in Q1 2026.
- Historically, Retained Earnings has averaged -$99.5 million across 5 years, with a median of -$140.5 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 92.13% in 2025 and fell as far as 1316.68% in 2025.
- Harvard Bioscience's Retained Earnings stood at -$15.1 million in 2022, then slumped by 867.35% to -$145.6 million in 2023, then jumped by 89.24% to -$15.7 million in 2024, then tumbled by 1270.2% to -$214.7 million in 2025, then slipped by 1.59% to -$218.1 million in 2026.
- Business Quant data shows HBIO's Retained Earnings at -$218.1 million in Q1 2026, -$214.7 million in Q4 2025, and -$12.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -221.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -221.04 Mn |
| Mar 31, 2026 | -218.13 Mn |
| Dec 31, 2025 | -214.71 Mn |
| Sep 30, 2025 | -12.44 Mn |
| Jun 30, 2025 | -210.63 Mn |
| Mar 31, 2025 | -208.35 Mn |
| Dec 31, 2024 | -15.67 Mn |
| Sep 30, 2024 | -158.03 Mn |
| Jun 30, 2024 | -14.87 Mn |
| Mar 31, 2024 | -14.77 Mn |
| Dec 31, 2023 | -145.61 Mn |
| Sep 30, 2023 | -15.28 Mn |
| Jun 30, 2023 | -142.55 Mn |
| Mar 31, 2023 | -141.57 Mn |
| Dec 31, 2022 | -15.05 Mn |
| Sep 30, 2022 | -140.52 Mn |
| Jun 30, 2022 | -13.24 Mn |
| Mar 31, 2022 | -10.73 Mn |
| Dec 31, 2021 | -10.03 Mn |
| Sep 30, 2021 | -15.00 Mn |